Sep 21, 2026 04:15PM
May 12, 2026 04:15PM
Mar 3, 2026 04:15PM
Jan 6, 2026 04:15PM
Nov 10, 2025 09:00AM
Nov 10, 2025 09:00AM
Nov 10, 2025 09:00AM Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis
Nov 4, 2025 04:15PM
Sep 29, 2025 04:07PM
Sep 29, 2025 04:05PM
Apr 17, 2025 07:00AM
Jan 7, 2025 09:15AM
Jul 19, 2024 02:20AM
May 22, 2023 03:58AM JPMorgan Upgrades AnaptysBio (ANAB) to Neutral
Sep 1, 2022 09:15AM
Aug 31, 2022 05:17PM
Jan 5, 2022 04:05PM
Jan 5, 2022 04:05PM
Mar 8, 2021 12:04PM
Mar 8, 2021 09:32AM
Feb 11, 2021 06:53AM UPDATE: JPMorgan Upgrades AnaptysBio (ANAB) to Overweight
Jan 7, 2021 04:15PM
Jan 7, 2021 04:15PM
Oct 14, 2020 09:22AM
Jan 8, 2020 04:00PM
Jan 8, 2020 04:00PM
Nov 8, 2019 10:54AM
Oct 1, 2019 09:17AM Pre-Open 10/01: (GERN) (ADT) (MNK) Higher (NERV) (AMTD) (ETFC) Lower (more...)
Jan 2, 2019 06:30AM
Jan 2, 2019 06:30AM
Nov 21, 2018 05:16AM
Sep 28, 2018 04:05PM
Sep 28, 2018 04:05PM
Sep 26, 2018 05:53AM
Sep 25, 2018 07:49PM AnaptysBio Announces Pricing of Public Offering of Common Stock
Sep 25, 2018 07:49PM
Sep 24, 2018 04:03PM
Sep 24, 2018 04:01PM
Sep 24, 2018 04:01PM
Jan 2, 2018 06:30AM
Jan 2, 2018 06:30AM

301,139 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All